YiPSCELL
PrivateLast Round
Series C
Oct 26, 2026
Est. Valuation
$44.78M
Total Funding Raised
$35.61M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
YiPSCELL operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series C round in October 2026.
YiPSCELL is a biotechnology company that develops induced pluripotent stem cell (iPSC)-derived therapies and disease modeling platforms for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YiPSCELL Comparables
Compare YiPSCELL with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cynata Therapeutics Limited | 78% | |
| SereNeuro Therapeutics | 76% | |
| Axol Bioscience | 74% |
For institutional investors. Book with your work email.
YiPSCELL Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Oct 26, 2026 | ||||
| Grant | Jun 23, 2026 | ||||
| Grant | Oct 31, 2023 | ||||
| Corporate Funding | Feb 5, 2023 | ||||
| VC Round | Dec 28, 2022 | ||||
Series A | Jun 9, 2021 |
For institutional investors. Book with your work email.
YiPSCELL Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series A, Series C, VC Round |
| KOTEC | Grant |
| Premier Partners | Series A, Series C, VC Round |
| Big Move Ventures | Series C |
| HB Investment | Series A, Series C, Grant, VC Round |
| Korea Venture Investment Corporation | Series C |
| Government of South Korea | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 26, 2026
$9M round led by Big Move Ventures
- Jun 23, 2026
$430K raised from Government of South Korea and KOTEC.
For institutional investors. Book with your work email.
YiPSCELL Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about YiPSCELL's valuation, stock price, and market status.
Is YiPSCELL a public or private company?
YiPSCELL is a private company.
What is the current stock price of YiPSCELL?
YiPSCELL is a private company, so its shares have no public market price. Caplight tracks YiPSCELL's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is YiPSCELL worth (valuation)?
YiPSCELL's valuation is estimated at $44.8M based on funding round data.
Can I buy YiPSCELL stock?
YiPSCELL shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was YiPSCELL's last funding round?
YiPSCELL's most recent funding round was Series C on October 26, 2026.
Who are the main investors in YiPSCELL?
Key investors in YiPSCELL include InterVest, Big Move Ventures, Government of South Korea.
Will YiPSCELL IPO soon?
No public IPO plans have been announced for YiPSCELL.
How can I track YiPSCELL secondary market activity?
Caplight tracks bids, offers, and trades in YiPSCELL's shares on secondary markets.